Phase II trial of weekly bortezomib in combination with rituximab in untreated patients with Waldenström Macroglobulinemia
I. Ghobrial, Wan-Ling Xie, S. Padmanabhan, A. Badros +13 more
2010American journal of hematology/oncology143 citations
Semantic Scholar

